Regenerative Biotechnology
CTM Capillary + D
Mesenchymal stem cells with dutasteride for adjuvant treatment of androgenic alopecia.
Subdermal solution of native mesenchymal stem cells with dutasteride designed to modulate inflammation, stimulate follicular regeneration, and reduce hair follicle miniaturization.
Composition
Native mesenchymal stem cells and dutasteride.
Pharmaceutical form
Solution.
Monovette con 1 ml.
Monovette with 4 ml.
Therapeutic properties
Promotes hair follicle repair through immunomodulation, growth factor secretion, collagen stimulation, increased cellular proliferation, apoptosis inhibition, and reduction of dihydrotestosterone via 5α-reductase blockade.
- Stimulation of follicular regeneration.
- Reduction of scalp inflammation.
- Inhibition of follicular miniaturization.
- Reduction of local dihydrotestosterone.
- Increase in cellular proliferation.
- Inhibition of follicular apoptosis.
- Local immunomodulatory action.
- Support for hair recovery.
Mechanism of action & Clinical data
Las CTM migran al folículo piloso, secretan factores regenerativos e inmunomodulan; la dutasterida inhibe 5α-reductasa tipo 1 y 2, reduciendo DHT.
Indications
Adjuvant treatment for androgenic alopecia.
Administration
Subdermal application with 30G x 13 mm needle, 0.2 ml per point spaced 1 cm apart.
Contraindications
Hypersensitivity to formula components. Diagnosis of neoplasia. Pregnancy and breastfeeding.
Storage
Store refrigerated between 2–5 °C, protected from direct sunlight. Do not freeze.
